Our present study found that ERbeta2 is upregulated in some TNBC cells and promotes TNBC cell growth, migration and invasion by regulating hsa_circ_0000732 targeting miR-1184. The special role of ERbeta2 in TNBC may be the breakthrough of a targeted treatment strategy for TNBC.
Estrogen receptor beta2 (ERbeta2)-mediated upregulation of hsa_circ_0000732 promotes tumor progression via sponging microRNA-1184 in triple-negative breast cancer (TNBC).